Exceptionally low likelihood of Alzheimer’s dementia in APOE2 homozygotes from a 5,000-person neuropathological study
Alzheimer's Association · Translational Genomics Research Institute · +81 more institutions
Abstract
Each additional copy of the apolipoprotein E4 (APOE4) allele is associated with a higher risk of Alzheimer's dementia, while the APOE2 allele is associated with a lower risk of Alzheimer's dementia, it is not yet known whether APOE2 homozygotes have a particularly low risk. We generated Alzheimer's dementia odds ratios and other findings in more than 5,000 clinically characterized and neuropathologically characterized Alzheimer's dementia cases and controls. APOE2/2 was associated with a low Alzheimer's dementia odds ratios compared to APOE2/3 and 3/3, and an exceptionally low odds ratio compared to APOE4/4, and the impact of APOE2 and APOE4 gene dose was significantly greater in the neuropathologically…
Citation impact
- FWCI
- 33.71
- Percentile
- 100%
- References
- 35
Authors
192- EMEric M. ReimanCorresponding
Alzheimer's Association, Translational Genomics Research Institute, Banner Health, Arizona Alzheimer’s Consortium
- JFJoseph F. Arboleda‐Velásquez
Massachusetts Eye and Ear Infirmary, Harvard University, Smith-Kettlewell Eye Research Institute
- YTYakeel T. Quiroz
Harvard University, Massachusetts General Hospital
- MJMatthew J. Huentelman
Translational Genomics Research Institute
- TGThomas G. Beach
Alzheimer's Association, Arizona Alzheimer’s Consortium
Topics & keywords
- Dementia
- Medicine
- Neuroscience
- Gerontology
- Biology
- Genetics
- Bioinformatics
- Psychiatry
- Good health and well-being
Funding
- UDU.S. Department of Veterans Affairs
- MJMichael J. Fox Foundation for Parkinson's ResearchAwards: 05-901, 211002
- PPfizer
- BABrigham and Women's Hospital
- UOUniversity of Southern California
- CHChildren's Hospital of Philadelphia
- BYBrigham Young University
- UOUniversity of Pennsylvania
- EUEmory University
- NUNorthwestern University
- ADArizona Department of Health ServicesAwards: RC2AG036528, AG041718, AG030653, 05-901, U01AG032984, 211002
- CCCleveland Clinic
- NANancy and Buster Alvord Endowment
- UOUniversity of WashingtonAward: P50AG005136
- JHJohns Hopkins University
- UOUniversity of PittsburghAwards: AG030653, AG041718
- RURush University
- UOUniversity of South Florida
- UOUniversity of North Texas
- UHUSF Health Byrd Alzheimer's Institute
- HCHope Center for Neurological Disorders
- YUYork University
- ABArizona Biomedical Research CommissionAwards: 05-901, 211002
- UOUniversity of California, Los Angeles
- UOUniversity of California, San Diego
- PSPerelman School of Medicine, University of Pennsylvania
- FSFeinberg School of Medicine
- UOUniversity of California, Irvine
- GRGeriatric Research Education and Clinical Center
- MRMedical Research CouncilAwards: MR/L501542/1, MR/N026004/1
- NINational Institute on AgingAwards: 211002, RC2AG036528, RF1AG057519, U24NS072026, P50AG005136, U01AG046139, AG041718, AG030653, R01AG17917, U01AG032984, R01AG031581, U01AG006781, R01AG048927, P30AG19610, R01AG15819, 05-901, RF1AG057519, P30-AG10161, R01AG15819, R01AG17917, AG005133, P30AG10161, RF1NS110048, U24AG041689
- NINational Institute of Neurological Disorders and StrokeAwards: U24NS072026, RF1NS110048, 211002, R01NS080820, 05-901
- NCNIH Clinical Center
- UOUniversity of Colorado School of Medicine, Anschutz Medical Campus